BROMOCRIPTINE POTENTIATION OF GASTRIC ACID SECRETION IN CATS
- 1 November 1976
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 5 (6) , 723-729
- https://doi.org/10.1111/j.1365-2265.1976.tb03876.x
Abstract
Bromocriptine administered both orally and i.v. potentiated gastric acid secretion in response to submaximal pentagastrin stimulation in cats. Bromocriptine did not increase the maximum acid secretion in response to pentagastrin, nor did it stimulate basal acid secretion. Potentiation was observed in normal and vagotomized animals which precludes involvement of the vagi in the response. The mechanism of action of this compound on the stomach does not appear to be mediated through stimulation of dopaminergic receptors as no potentiation was observed with dopamine infusions. The bromocriptine potentiation of gastric acid secretion may be a demonstration of 5-hydroxytryptamine or .alpha.-adrenergic antagonism. However, the potentiation observed with daily oral bromocriptine treatment had disappeared by the 8th day and may correlate with the disappearance of gastric side effects noted in patients on bromocriptine treatment.This publication has 15 references indexed in Scilit:
- Metoclopramide Stimulates Prolactin Secretion in ManJournal of Clinical Endocrinology & Metabolism, 1976
- BROMOCRIPTINE IN PARKINSONISMThe Lancet, 1975
- DOPAMINE IS AN IMPORTANT NEUROTRANSMITTER IN THE AUTONOMIC NERVOUS SYSTEMThe Lancet, 1975
- Bromocriptine in ParkinsonismBMJ, 1974
- Suppression of Prolactin Release by a Purified Porcine PIF Preparation and Catecholamines Infused into a Rat Hypophysial Portal VesselEndocrinology, 1974
- The effect of histamine-H2-receptor-antagonists on gastric acid secretion, gastric mucosal blood flow and acid base balance in catsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974
- Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neuronsJournal of Pharmacy and Pharmacology, 1973
- THE INHIBITION OF PROLACTIN SECRETION IN MAN BY CB-154 (2-Br-α-ergocryptine)Journal of Clinical Endocrinology & Metabolism, 1972
- Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptineBMJ, 1972
- Studies on the responses of the isolated nictitating membrane of the catThe Journal of Physiology, 1958